NCT05146466

Brief Summary

Hypothesis: Is it feasible to conduct a definitive trial to test the effect of E-MATVR compared to E-MATE on primary and secondary outcomes among Gaelic Athletic Association (GAA) members (players and coaches)? The overall aim of this study is to examine the feasibility of conducting a definitive trial to test the effect of an educational intervention to Enhance Men's Awareness of Testicular diseases using Virtual Reality (E-MATVR) among male GAA members. The effect of E-MATVR will be compared to E-MATE (control) which involves using the same information as E-MATVR delivered as plain text (e.g., PDF) with still images from E-MATVR.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 6, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

March 15, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 22, 2022

Completed
Last Updated

November 30, 2022

Status Verified

November 1, 2022

Enrollment Period

8 months

First QC Date

October 29, 2021

Last Update Submit

November 29, 2022

Conditions

Keywords

Testicular DiseasesTechnologyAthletesKnowledgeSocial MediaVirtual Reality

Outcome Measures

Primary Outcomes (2)

  • Testicular Knowledge Questionnaire

    Change in participants' knowledge of the normal testes, testicular symptoms, testicular self-examination, and testicular diseases as assessed by the Testicular Knowledge Questionnaire comprising 8 multiple choice questions and 4 'True' and 'False' type questions. All 12 items are dichotomised into "Correct=1" and "Incorrect/Don't know=0." Scores range between 0 and 12. Higher scores indicate greater knowledge.

    T0 (baseline), T1 (immediately post-test), T2 (three months post-test)

  • Testicular Self-Examination Behaviour Questionnaire

    Change in participants' behaviours in relation to feeling their own testes and advising at least one man to do the same as assessed by the Testicular Self-Examination Behaviour Questionnaire comprising 3 'Yes' and 'No' type questions. All items are dichotomous: "Yes=1" and "No=0."

    T0 (baseline), T2 (three months post-test)

Secondary Outcomes (4)

  • Testicular Awareness Scale

    T0 (baseline), T1 (immediately post-test), T2 (three months post-test)

  • Implementations Intentions Scale

    T0 (baseline), T1 (immediately post-test), T2 (three months post-test)

  • Perceived Risk Item

    T0 (baseline), T1 (immediately post-test), T2 (three months post-test)

  • General Help-Seeking Questionnaire

    T0 (baseline), T1 (immediately post-test), T2 (three months post-test)

Study Arms (2)

E-MATVR (intervention)

OTHER
Behavioral: E-MATVR

E-MATEE (control)

OTHER
Behavioral: E-MATE

Interventions

E-MATVRBEHAVIORAL

It involves using computer software uploaded onto wireless virtual reality (VR) technology (similar to downloading an app on a mobile phone) and will be delivered using a headset, handheld controllers, and voiceover (all wireless). E-MATVR comprises three serious gaming levels aimed at familiarising men with the normal look and feel of the testes, common testicular symptoms and diseases, and the importance of early help-seeking.

E-MATVR (intervention)
E-MATEBEHAVIORAL

It involves using the same information as EMATVR delivered as plain text (e.g., PDF) with still images from E-MATVR. Participants will be given approximately 10 minutes to read the text/look at images using a tablet (e.g., iPad).

E-MATEE (control)

Eligibility Criteria

Age18 Years - 50 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsThe current project involves awareness of male-specific diseases (i.e. testicular diseases). Therefore, cis (biological) males, transwomen (male to female), and non-binary/gender nonconforming/gender neutral individuals who are biologically male will be eligible for inclusion. Individuals who are not biologically male will be welcome to interact with E-MATVR/E-MATE if desired; however, their participation will not be recorded.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Biological males.
  • Members of the target GAA clubs (GAA players and coaches) since testicular injuries are common in field sports like hurling.
  • Residing in Ireland.
  • Aged 18-50 years (age group at risk for testicular diseases).

You may not qualify if:

  • History of seizures.
  • History of motion sickness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Up to 12 geographically dispersed GAA clubs in Cork and neighbouring counties

Cork, Munster, Ireland

Location

Related Publications (3)

  • Viechtbauer W, Smits L, Kotz D, Bude L, Spigt M, Serroyen J, Crutzen R. A simple formula for the calculation of sample size in pilot studies. J Clin Epidemiol. 2015 Nov;68(11):1375-9. doi: 10.1016/j.jclinepi.2015.04.014. Epub 2015 Jun 6.

    PMID: 26146089BACKGROUND
  • Murphy A, Kirby A, De Blasio F, McCarthy M, Shiely F, Hegarty J, Davoren MP, Harrington JM, Shorter GW, Murphy D, O'Mahony B, Cooke E, Rovito MJ, Robertson S, FitzGerald S, Connor AO, Riordan MO, Saab MM. Cost-Benefit Analysis of the Enhancing Men's Awareness of Testicular diseases (E-MAT) Feasibility Trial: A Virtual Reality Experience to Increase Testicular Knowledge and Self-Examination among Male Athletes. Pharmacoecon Open. 2025 Jul;9(4):671-682. doi: 10.1007/s41669-025-00571-5. Epub 2025 Mar 19.

  • Saab MM, McCarthy M, Davoren MP, Shiely F, Harrington JM, Shorter GW, Murphy D, O'Mahony B, Cooke E, Murphy A, Kirby A, Rovito MJ, Robertson S, FitzGerald S, O'Connor A, O'Riordan M, Hegarty J, Dahly D. Enhancing Men's Awareness of Testicular Diseases (E-MAT) using virtual reality: A randomised pilot feasibility study and mixed method process evaluation. PLoS One. 2024 Jul 22;19(7):e0307426. doi: 10.1371/journal.pone.0307426. eCollection 2024.

Related Links

MeSH Terms

Conditions

Testicular Diseases

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesMale Urogenital DiseasesGonadal DisordersEndocrine System Diseases

Study Officials

  • Mohamad M Saab, PhD, MSc, PGDTLHE, RGN

    University College Cork

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Given the differences between the two arms, participants will be aware of the arm they have been randomised into. Outcome assessments will be self-reported and returned to research staff with no information on allocation. Blinding will be maintained throughout data analysis. Unblinding will be facilitated by the independent statistician following completion of the protocol-specified data analysis.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Data will be collected in up to 12 Gaelic Athletic Association (GAA) sports clubs. For each of the participating GAA clubs, individual participants will be randomised with the same probability to one of the two arms (E-MATVR \[intervention\]/E-MATE \[control\]). Allocation concealment will be maintained using a computerised system. Once participants have consented and their baseline assessment has been entered into the computer database, their allocation will be given by automated email. Randomisation and allocation concealment will be conducted according to the standard operating procedures (SOPs) of the Statistics and Data Analysis Unit of the HRB Clinical Research Facility-Cork (HRB CRF-C).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

October 29, 2021

First Posted

December 6, 2021

Study Start

March 15, 2022

Primary Completion

November 22, 2022

Study Completion

November 22, 2022

Last Updated

November 30, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations